Immunization News and Research

RSS

Factors impacting anti-SARS-CoV-2 antibodies in healthcare personnel

In a recent study posted to the medRxiv* preprint server, researchers assessed variables that influence anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers in medical professionals.

16 May 2022

An Ad5 vectored COVID vaccine expressing an S1-N fusion protein

In a recent study posted to the bioRxiv* preprint server, researchers characterized the development of multiple adenovirus-vectored and subunit recombinant protein severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidates.

12 May 2022

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

A recent study published in the journal Antiviral Research explored alternative sources of polyclonal antibodies against SARS-CoV-2, which would be more cost-effective, amendable to regulatory approval, and widespread use.

12 May 2022

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

In a recent study published in the journal Vaccines, researchers revealed how severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron evades neutralizing antibodies (nAbs).

12 May 2022

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Researchers reviewed messenger ribonucleic acid (mRNA) technology and highlighted its clinical applications.

11 May 2022

Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

A new study explored key vaccine features which could help induce and preserve humoral immunity against SARS-CoV-2 infection.

11 May 2022

Comparison of COVID-19 vaccination schemes

Researchers assessed SARS-CoV-2 neutralizing antibodies in Chile.

9 May 2022

COVID-19 booster or additional primary vaccination dose against SARS-CoV-2 Omicron in nursing home occupants

A recent study assessed the efficacy of SARS-CoV-2 primary series vaccination, additional initial dose, or booster shot against the SARS-CoV-2 Omicron infection in the nursing home.

9 May 2022

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

A recent article published in Science Translational Medicine demonstrated that mucosally delivered adenovirus type 5 (Ad5)-based COVID-19 vaccination minimized COVID-19 transmission and severity.

9 May 2022

Obesity increased among children, teens from low-income families during early pandemic months

During the first six months of the COVID-19 pandemic, the proportion of children and adolescents from low-income families with overweight or obesity increased markedly, according to new research being presented at this year's European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May).

8 May 2022

Evaluation of the potential of new and repurposed TB vaccines

A new study evaluated effective vaccination strategies for two TB vaccines, M72/AS01E and BCG.

5 May 2022

The war against COVID-19: reinfection, vaccines, and herd immunity

A communication published in the journal Epidemiologia aimed to answer several questions concerning neutralizing antibodies against SARS-CoV-2, herd immunity, and COVID-19 vaccines.

4 May 2022

The extent to which COVID-19 vaccination rates and vaccine hesitancy are associated with levels of online vaccine misinformation

A new study has determined the link between vaccine hesitancy, vaccination rates, and online misinformation across the US.

4 May 2022

Researchers reveal the mechanism of action of century-old BCG vaccine

The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world's oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with endemic TB, it has surprisingly been found to protect newborns and young infants against multiple bacterial and viral infections unrelated to TB. There's even some evidence that it can reduce severity of COVID-19.

4 May 2022

Immunization News and Research

Factors impacting anti-SARS-CoV-2 antibodies in healthcare personnel

An Ad5 vectored COVID vaccine expressing an S1-N fusion protein

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

Comparison of COVID-19 vaccination schemes

COVID-19 booster or additional primary vaccination dose against SARS-CoV-2 Omicron in nursing home occupants

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

Obesity increased among children, teens from low-income families during early pandemic months

Evaluation of the potential of new and repurposed TB vaccines

The war against COVID-19: reinfection, vaccines, and herd immunity

The extent to which COVID-19 vaccination rates and vaccine hesitancy are associated with levels of online vaccine misinformation

Researchers reveal the mechanism of action of century-old BCG vaccine

Researchers investigate the population-level consequences of wearing masks

Scientists discover a potential new method of active immunization to prevent Alzheimer's disease

Multivalent messenger ribonucleic acid-lipid nanoparticle vaccines against SARS-CoV-2

The generation of SARS-CoV-2 virus-like particles in insect cells

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News